Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1

Conditions

Lymphoma 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Leukemia 13Lymphoma, Non-Hodgkin 11Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Leukemia, Myeloid, Acute 7Myelodysplastic Syndromes 6Leukemia, Lymphocytic, Chronic, B-Cell 6Sarcoma 5Neuroblastoma 5Neoplasms 5Lymphoma, Mantle-Cell 5Burkitt Lymphoma 5Lymphoma, Large B-Cell, Diffuse 4Hodgkin Disease 4Hematologic Neoplasms 3Hematologic Diseases 3Breast Neoplasms 3Testicular Neoplasms 2Teratoma 2Retinoblastoma 2Preleukemia 2Precancerous Conditions 2Neoplasms by Histologic Type 2Myeloproliferative Disorders 2Lymphoproliferative Disorders 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Lymphatic Diseases 2Leukemia, Myelomonocytic, Juvenile 2

Interventions

Paclitaxel 134Carboplatin 129Bevacizumab 86Gemcitabine 45pembrolizumab 37olaparib 33Cisplatin 30liposomal doxorubicin 29Docetaxel 29Cyclophosphamide 29Topotecan 28niraparib 27Taxes 20Etoposide 18Filgrastim 16Doxorubicin 16Immunoglobulin G 15Disulfides 15apatinib 12Letrozole 12Albumin-Bound Paclitaxel 12Drug Therapy 11fluzoparib 10fludarabine 10Specimen Handling 10Magnetic Resonance Spectroscopy 10Biopsy 10durvalumab 9Nivolumab 9pazopanib 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Ovarian Neoplasms × Mesna × Clear all
NCT00432094 2022-05-17

Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors

Masonic Cancer Center, University of Minnesota

Phase 2 Completed
23 enrolled 11 charts
GenitourinaryGynecologic

Ovarian Germ Cell Cancer, Ovarian Neoplasms, Teratoma, Testicular Neoplasms, Carcinoma, Embryonal, Seminoma, Endodermal Sinus Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡